Treat Glaucoma Effectively with Lumigan Bimatoprost Eye Drop
Bimatoprost under the brand name Lumigan is widely used in the USA, Canada, and Europe to control the advancement of glaucoma which is an eye disease that harms the optic nerve and impairs vision (sometimes building up to blindness). Manufactured by Allergan, Inc., Lumigan is a prostaglandin analog used topically in the form of eye drops. It is also indicated to manage ocular hypertension in patients. The mechanism of action for Lumigan (Bimatoprost) lies in the increase of the outflow of aqueous fluid from the eyes to reduce intraocular pressure (IOP).Prescription is required to buy Lumigan
Lately, Bimatoprost under a different brand name Latisse is being used to lengthen eyelashes. However, it was initially prescribed off-label for growing eyelashes. This cosmetic formulation of Bimatoprost got the approval from the US Food and Drug Administration (FDA) in December 2008. Moreover, minimum of three recent case series on Bimatoprost have explored the capability of this medication in reducing adipose (fat) tissue.
Lumigan (Bimatoprost Opthalmic Solution) is commonly available in medicated eye drops of 0.03% strength. People with open-angle glaucoma or ocular hypertension are prescribed to use this opthalmic solution once a day to lessen their intraocular pressure (IOP). As mentioned earlier, Bimatoprost acts by increasing the depletion of aqueous humor through two different pathways out of the eye. This particular method of drainage through two channels makes Lumigan quite effective against IOP and glaucoma.
If your healthcare provider has prescribed you Lumigan opthalmic solution, then he or she is quite certain that you have either glaucoma (open-angle glaucoma) or ocular hypertension (raised IOP). Glaucoma is an eye condition that can not be cured completely. But, clinical studies financed by National Eye Institute have established that you can significantly cut down the risk for visual field loss by reducing elevated IOP level.
Before using Lumigan (Bimatoprost) therapy, you must be aware of certain important safety information about the medication. This 0.03% opthalmic solution is believed to cause blackening or pigmentation of eye color, eyelid skin, and eyelashes. Many patients have also reported the impact of the drug on increasing the growth of eyelashes. The alteration of pigmentation can continue to increase as long as Lumigan is applied. Once you discontinue the eye drop, the pigmentation of eyelid skin and eyelashes may return to their previous state. But, the darkening of the eye color is more or less permanent. There is no information on the outcomes of amplified blackening beyond a period of 5 years.